Tasso provides a needle‑free, self‑administered blood collection system that lets patients draw capillary blood at home using single‑use Tasso+ or Tasso Mini devices. The company handles end‑to‑end logistics—including kit shipping, live remote guidance, prepaid return shipping, and a cloud portal or API for sample tracking and results—enabling healthcare providers and researchers to run decentralized trials and frequent at‑home sampling without in‑person phlebotomy.
Funding
$100M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
8OFounders
Product
Problem
Traditional blood collection relies on venipuncture or finger sticks performed in clinics, which can be painful, require trained staff, and limit patient participation in frequent or remote testing.
Solution
Tasso offers a needle‑free, self‑administered blood collection system that uses a small lancet and vacuum to draw capillary blood into standard collection tubes. The devices are single‑use, CE‑marked, FDA‑cleared, and compatible with both liquid and dried sample formats. An end‑to‑end logistics platform handles kit shipping, live proctoring, SMS reminders, and prepaid return of samples to a laboratory. Results are delivered through a web portal (Tasso Connect) or API, enabling seamless integration with existing clinical or research workflows. By eliminating the need for in‑person phlebotomy, Tasso improves patient experience, increases enrollment and retention in decentralized trials, and supports higher‑frequency sampling for sensitive populations.
Target Audience
Primary customers are healthcare providers, clinical laboratories, pharmaceutical companies, and contract research organizations that run decentralized clinical trials or require frequent at‑home blood sampling, especially for pediatric or other sensitive populations.
Features
- Single‑use Tasso+ and Tasso Mini devices that collect 200‑600 µL of whole capillary blood without a hollow needle
- Optional dried‑blood‑spot (Tile‑T20) format for pharmacokinetic or therapeutic drug monitoring
- Integrated adhesive and vacuum mechanism that activates with a button press, requiring no medical training
- Prepaid, UN3373‑compliant shipping kit with live remote guidance and automated SMS reminders
- Cloud‑based Tasso Connect portal and open API for real‑time sample tracking and results delivery
- Regulatory clearances (FDA 510(k) Class II, CE Mark, MHRA, Health Canada) for clinical‑grade use
- Compatibility with standard microtainer tubes and cartridge reservoirs for flexible downstream processing